Edwards Lifesciences (EW) Enterprise Value (2009 - 2026)

Edwards Lifesciences has reported Enterprise Value for 18 years, with the latest figure at $48.0 billion in Q2 2026.

• On a quarterly basis, Enterprise Value rose 14.38% year-over-year to $48.0 billion in Q2 2026; TTM through Jun 2026 was $48.0 billion, a 14.38% increase from a year earlier, with the FY2025 full-year figure at $45.3 billion, up 14.16% from the prior year.
• Enterprise Value was $48.0 billion for Q2 2026 at Edwards Lifesciences, up from $42.5 billion in the prior quarter.
• The five-year high for Enterprise Value was $71.7 billion in Q1 2022, with the low at $34.5 billion in Q3 2024.
• Average Enterprise Value over 5 years is $47.4 billion, with a median of $44.8 billion recorded in 2023.
• The largest YoY upside for Enterprise Value was 41.4% in 2022 against a maximum downside of 44.36% in 2022.
• Over 5 years, Enterprise Value stood at $44.2 billion in 2022, then rose by 0.23% to $44.3 billion in 2023, then fell by 10.41% to $39.7 billion in 2024, then climbed by 14.16% to $45.3 billion in 2025, then rose by 6.04% to $48.0 billion in 2026.
• The last three Enterprise Value figures came in at $48.0 billion (Q2 2026), $42.5 billion (Q1 2026), and $45.3 billion (Q4 2025), per Business Quant data.